Search database
Filter
2037
Text search: Antiretroviral Drugs
Featured
Language
Document type
1459
229
199
47
33
25
24
10
9
2
Countries
77
71
66
57
54
48
46
45
37
36
36
34
32
32
28
28
28
27
27
26
25
24
24
24
20
17
16
16
16
15
15
13
12
11
10
10
7
7
7
7
7
6
6
5
5
5
5
5
4
4
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
194
168
162
161
92
50
48
29
29
26
22
22
18
17
17
16
14
14
14
12
12
12
12
12
11
11
11
10
10
10
10
9
9
9
8
8
8
7
7
7
7
7
7
7
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Publication Years
Category
813
178
84
57
43
28
20
1
Toolboxes
651
260
47
41
37
30
24
22
19
14
13
12
12
12
11
8
7
4
3
1
1
 Download
  View PDF
 Add to my MEDBOX

Annex 3. Dosages of ARV drugs

World Health Organization (2019) C_WHO
Accessed: 19.10.2019
 Download
  View PDF
 Add to my MEDBOX

Harm Reduction save lives - HIV and people who inject Drugs

UNAIDS (Joint United Nations Programme on HIVAIDS) (2017) C2
 External Link
 Add to my MEDBOX

Interventions to improve antiretroviral therapy adherence among adolescents in low- and middle-income countries: A systematic review of the literature

K. Ridgeway; L. S. Dull K. R. Murray; et al. PLOS ONE (2018) CC
Research Article PLOS ONE | https://doi.org/10.1371/journal.pone.0189770 January 2, 2018
 Download
  View PDF
 Add to my MEDBOX

Guideline: Adherence to antiretroviral therapy in adolescents and young adults (expanded version)

L. Fairlie; L. Jankelowitz; H. Ronald; et al. Southern African HIV Clinicians Society; Right to Care (Training Health Seriously) (2017) C2
Recommendations, resources and references A publication of the Southern African HIV Clinicians Society
 Download
  View PDF
 Add to my MEDBOX

Guidance on couples HIV testing and counselling including antiretroviral therapy for treatment and prevention in serodiscordant couples: recommendations for a public health approach

World Health Organization WHO (2012) C_WHO
 Download
  View PDF
 Add to my MEDBOX

Update of recommendations on first- and second-line antiretroviral regimens - Policy Brief

World Health Organization (2019) C_WHO
HIV Treatment
 Download
  View PDF
 Add to my MEDBOX

Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy

World Health Organization (WHO) (2017) C_WHO
The objectives of these guidelines are to provide recommendations outlining a public health approach to managing people presenting with advanced HIV disease, and to provide guidance on the timing of initiation of antiretroviral therapy (ART) for all ... more
 Download
  View PDF
 Add to my MEDBOX

Women speak out: understanding women who inject drugs in Indonesia

Indonesian Drug Users Network (2016) C1
 Download
  View PDF
 Add to my MEDBOX

Good practices in Europe: HIV prevention for People Who Inject Drugs implemented by the International HIV/AIDS Alliance in Ukraine

World Health Organization (Europe) World Health Organization (Europe) (2014) C_WHO
July 2014
 External Link
 Add to my MEDBOX

The impact of HIV and antiretroviral therapy on TB risk in children: a systematic review and meta-analysis

P. J. Dodd; A. J. Prendergas; C. Beecroft; et al. BMJ Journals (2017) CC
BMJ,Dodd PJ, et al. Thorax 2017;72:559–575. doi:10.1136/thoraxjnl-2016-209421
 Download
  View PDF
 Add to my MEDBOX

The Integrated National Guidelines on Antiretroviral Therapy Prevention of Mother to Child Transmission of HIV Infant & Young Child Feeding

Ministry of Health Uganda (2012) C1
1st edition
 External Link
 Add to my MEDBOX

Shadow Report - On the situation of women who use drugs, women living with HIV, sex workers, and lesbian, bisexual women and transgender people in Ukraine

Legalife-Ukraine; Insight; Positive Women; Svitanok; echo.net (2017) C2
Prepared by NGOs: “Legalife-Ukraine”, “Insight”, “Positive Women”, and “Svitanok” For the submission to the 66th CEDAW Session Geneva, Switzerland 13 February 2017 - 03 March 2017
 Download
  View PDF
 Add to my MEDBOX

HIV stigma and associated factors among antiretroviral treatment clients in Jimma town, Southwest Ethiopia

N. N. Fido; M. Aman; Z. Brihnu HIVAIDS - Research and Palliative Care; Dovepress; PMC (US National Library of Medicine National Institutes of Health) (2016) CC
HIV/AIDS - Research and Palliative Care 2016:8 183–193
 Download
  View PDF
 Add to my MEDBOX

HIV and young people who inject drugs

A. Armstrong; J. Baer; R. Baggaley; et al. UNAIDS; World Health Organization; UNFPA; et al. (2015) C_WHO
Technical Brief
 Download
  View PDF
 Add to my MEDBOX

Implementing Comprehensive HIV and HCV Programmes with People Who Inject Drugs

UNAIDS, UNODC (United Nations Office on Drugs and Crime); World Health Organization; et al. (2017) C2
Practical Guidance for collaborative interventions
 External Link
 Add to my MEDBOX

Profiles of Peripheral CD4+T Cells Count during Antiretroviral Treatment in Senegalese Adults Infected by HIV: Impact of Therapeutic Associations

Niang M. S., R. Derwiche, B. Mbengue Journal of Immunology, Infection & Inflammatory Diseases (2017) CC
Thirty-three years after its discovery, the Human Immunodeficiency Virus (HIV), responsible for the AIDS pandemic, remains a major public health problem despite advanced researches providing better diagnostic and therapeutic tools. The virus targets especially CD4+ T cells, leading to deficiency of ... more
 External Link
 Add to my MEDBOX

A Concise Quality Control Guide on Essential Drugs and other Medicines

Jähnke, R.W.O. and Kornelia Dwornik (2021) CC
100 test methods for 100 active pharmaceutical ingredients For existing Minilab projects that want to replace old manuals or initiatives that want to start new projects, the new "Minilab Edition 2020" can be obtained at the preferential price of 50 € from our logistic partner Technologie Transfer ... more
 Download
  View PDF
 Add to my MEDBOX

Treatment of tuberculosis - Annex 6 Essential first-line antituberculosis drugs

World Health Organization (2017) C_WHO
Guidelines for treatment of drug-susceptible tuberculosis and patient care Uptsate 2017
 Download
  View PDF
 Add to my MEDBOX

Updated recommendations on first-line and second-line antiretroviral regimens and post-exposure prophylaxis and recommendations on early infant diagnosis of HIV - Policy Brief

World Health Organization (2018) C_WHO
HIV Treatment - Interim Guidance
 Download
  View PDF
 Add to my MEDBOX

Policy Brief to Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy

World Health Organization (2017) C_WHO
HIV treatment Policy brief July 2017 WHO/HIV/2017.18
 Download
  View PDF
 Add to my MEDBOX

Assessment of Impact of Harm Reduction Interventions among People who Inject Drugs (PWID) in Dhaka City

National AIDSSTD Program, Directorate General of Health Services; Ministry of Health and Family Welfare, Govt. of Bangladesh (2014) C1
 Download
  View PDF
 Add to my MEDBOX

Social network methods for HIV case-finding among people who inject drugs in Tajikistan

M. Kan; D. B. Garfinkel; O. Samoylova; et al. Journal of the International AIDS Society (2018) C2
Kan M et al. Journal of the International AIDS Society 2018, 21(S5):e25139 http://onlinelibrary.wiley.com/doi/10.1002/jia2.25139/full | https://doi.org/10.1002/jia2.25139
 Download
  View PDF
 Add to my MEDBOX

Guidance on the clinical management of acute and chronic harms of club drugs and novel psychoactive substances.

Abdulrahim, D.; and O. Bowden-Jones Novel Psychoactive Treatment UK Network (NEPTUNE) (2015) CC
 Download
  View PDF
 Add to my MEDBOX

Health, rights and drugs - Harm reduction, decriminalization, and zero discrimination for people who use drugs

UNAIDS (Joint United Nations Programme on HIVAIDS) (2019) C2
 External Link
 Add to my MEDBOX

Forecast analysis of any opportunistic infection among HIV positive individuals on antiretroviral therapy in Uganda

Rubaihayo, J., N.M. Tumwesigye, J. Konde-Lule, et al. BMC Public Health (2016) CC
BMC Public Health (2016) 16:766 DOI 10.1186/s12889-016-3455-5
 External Link
 Add to my MEDBOX

Stratégie d’utilisation des substances naturelles dans la prise en charge des personnes vivant avec le VIH : expérience du Burkina Faso

Nikiéma J. B., K. Djierro, J. Simpore et al. Ethnopharmacologia (2009) C2
Au Burkina Faso, les personnes vivant avec le VIH (PvVIH) ont régulièrement recours à des substances naturelles pour traiter certaines infections opportunistes. C’est ainsi que le suc des feuilles fraîches de Mitracarpus scaber Zucc. ex Schult. & Schult. f. (Rubiaceae) et de Senna alata (L.) R ... more
 Download
  View PDF
 Add to my MEDBOX

Guidance for Non-HIV-Specialized Providers Caring for HIV-Infected Residents Displaced from Disaster Areas - Essential Information for Managing HIV-Infected Patients Receiving Antiretroviral Therapy

HHS Panels (*) (2011)
The following information provides guidance to health care providers attending to the medical needs of HIV-infected adults (including pregnant women) or children displaced from disaster areas who have not yet secured HIV care in the areas where they have relocated. (*) - HHS Panel on ... more
 Download
  View PDF
 Add to my MEDBOX

Incidence and Prevalence of Opportunistic and Other Infections and the Impact of Antiretroviral Therapy Among HIV-infected Children in Low- and Middle- income Countries: A Systematic Review and Meta-a

M.-R. B-Lajoie; O. Drouin; G. Bartlett; et al. Clinical Infectious Diseases; Infectious Diseases Society of America (IDSA); hivma; Oxford; WHO (2016) C2
Clinical Infectious Diseases 1586 - 1594 • CID 2016:62 (15 June) • HIV/AIDS
 External Link
 Add to my MEDBOX

Incidence and Prevalence of Opportunistic and Other Infections and the Impact of Antiretroviral Therapy Among HIV-infected Children in Low- and Middle income Countries

B-Lajoie,MR. O. Drouin,G. Bartlett, et al. IDSA, HIVMA, et al. (2016) C2
A Systematic Review and Meta-analysis Clinical Infectious Diseases® 2016;62(12):1586–94
 Download
  View PDF
 Add to my MEDBOX

British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015(2016 interim update)

British HIV Association (2016) CC
The guidelines are aimed at clinical professionals directly involved with and responsible for the care of adults with HIV infection, and at community advocates responsible for promoting the best interests and care of HIV-positive adults. They should be read in conjunction with other published BHIVA ... more
 Add to my MEDBOX

Guidelines: updated recommendations on HIV prevention, infant diagnosis, antiretroviral initiation and monitoring
recommended

World Health Organization WHO (2021) C_WHO
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antire ... more
 Download
  View PDF
 Add to my MEDBOX

Integrating collaborative TB and HIV services within a comprehensive package of care for people who inject drugs (Russian Version)

World Health Organization (2016) C_WHO
The END TB Strategy Интеграция совместного оказания услуг в связи с ТБ и ВИЧ во всеобъемлющий пакет помощи для потребителей инъекционных наркотиков
 Download
  View PDF
 Add to my MEDBOX

Do no Harm - Health, Human Rights and people who use drugs

UNAIDS (Joint United Nations Programme on HIVAIDS) (2019) C2
Accessed: 07.11.2019
 Add to my MEDBOX

Enquêtes par sites sentinelles sur la résistance acquise du VIH au dolutégravir chez les personnes sous traitement antirétroviral incluant ce médicament

World Health Organisation (WHO) (2023) C_WHO
Avec l’essor des traitements antirétroviraux (TAR) à base de dolutégravir (DTG) pour soigner les personnes vivant avec le VIH dans le monde, il est important d’estimer la vitesse à laquelle la résistance acquise au DTG apparaît dans les populations sous TAR. Bien que la résistance au DT ... more
 Download
  View PDF
 Add to my MEDBOX

Impact of a Family Clinic Day intervention on paediatric and adolescent appointment adherence and retention in antiretroviral therapy: A cluster randomized controlled trial in Uganda

J. C. Graves; Peter Elyanu; C. J. Schellack; et al. PLOS One (2018) CC
PLOS ONE | https://doi.org/10.1371/journal.pone.0192068 March 9, 2018
 Download
  View PDF
 Add to my MEDBOX

Recommended package of interventions for HIV, viral hepatis and STI prevention, diagnosis, treatment and care for people who inject drugs: policy brief

World Health Organisation (WHO) (2023) C_WHO
HIV, viral hepatitis and STI epidemics, particularly among people who inject drugs and other key populations, continue to be fuelled by laws and policies criminalizing sex work; drug use or possession; diverse forms of gender expression and sexualit ... more
 Add to my MEDBOX

Update on the transition to dolutegravir-based antiretroviral therapy

World Health Organization WHO (2022) C_WHO
This technical report summarizes the discussions on the status of programmatic transition to tenofovir, lamivudine and dolutegravir (TLD) in low– and middle- income countries, addressing the best practices and major challenges faced by HIV programmes. The latest data on safety and efficacy of do ... more
 External Link
 Add to my MEDBOX

DNDi Strategic Plan 2021-2028 | DNDi - English version

DNDi - Drugs for neglected diseases initiative (2023) C2
Accessed on 04.04.2023 The Drugs for Neglected Diseases initiative (DNDi) is an international non-profit organization that discovers, develops, and delivers safe, effective, and affordable treatments for the most neglected patients
 Download
  View PDF
 Add to my MEDBOX

Tanzania: National Guidelines for Monitoring Medicines Safety

Tanzania Food & Drugs Authority (TFDA) (2010) C2
Made under Section 5 (c) of the Tanzania Food, Drugs and Cosmetics Act, 2003 | Second Edition
 Download
  View PDF
 Add to my MEDBOX

HIV in prisons Situation and needs assessment toolkit

United Nations Office4 on Drugs and Crime; European Monitoring Centre for Drugs and Drug Addiction (2010) C2
Advance copy.
 Download
  View PDF
 Add to my MEDBOX

North Macedonia

L. Savikj European Monitoring Centre for Drugs and Drug Addiction (2013) C2
A summary of the national drug situation
 Add to my MEDBOX

Standard Treatment Guidelines and Essential Medicines List for South Africa : Primary Healthcare Level 2020 edition

the Essential Drugs Programme, the PHCAdult Hospital Level Expert review Committee, the National Essential Medicines List Committee National Department of Health South Africa (2020) CC
The PHC STGs and EML should be used by healthcare workers providing care at clinics, community health centres, and gateway clinics at hospitals. Pharmaceutical and Therapeutics Committees (PTCs) are responsible for ensuring the availability of medicines listed in the PHC EML at those facilities, as ... more
 Download
  View PDF
 Add to my MEDBOX

Global overview of drug demand and supply - Latest trends, cross-cutting issues

United Nations Office on Drugs and Crime (2018) C2
World Drug Report 2018 -2-
 Download
  View PDF
 Add to my MEDBOX

EMCDDA Monographs

T. Rhodes; D. Hedrich European Monitoring Centre for Drugs and Drug Addiction (2010) C2
Harm reduction: evidence, impacts and challenges -10-
 Download
  View PDF
 Add to my MEDBOX

Ukraine country overview

European Monitoring Centre for Drugs and Drug Addiction (2019) C2
Accessed: 22.03.2019
 Download
  View PDF
 Add to my MEDBOX

Country overview: Tajikistan

European Monitoring Centre for Drugs and Drug Addiction (2015) C2
 Download
  View PDF
 Add to my MEDBOX

Country overview: Kyrgyzstan

European Monitoring Centre for Drugs and Drug Addiction (2015) C2
 Download
  View PDF
 Add to my MEDBOX

HIV testing and counselling in prisons and other closed settings

UNODC (United Nations of Drugs and Crime); UNAIDS; World Health Organization; United Nations office on drugs and crime (Vienna) (2009) C_WHO
Technical Paper
 Download
  View PDF
 Add to my MEDBOX

HIV prevention, treatment and care in prisons and other closed settings: a comprehensive package of interventions

World Health Organization; UNODC (United Nations Office on Drugs and Crime); UNAIDS; et al. (2013) C_WHO
Policy Brief
 Download
  View PDF
 Add to my MEDBOX

HIV and young people who sell sex

UNAIDS, UNODC (United Nations Office on Drugs and Crime); World Health Organization; MSMGF; et al. (2015) C_WHO
Technical Brief
 Download
  View PDF
 Add to my MEDBOX

HIV and AIDS in places of detention - A toolkit for policymakers, programme managers, prison officers and health care providers in prison settings

World Health Organization; United Nations office on drugs and crime (Vienna) (2008) C_WHO
 Download
  View PDF
 Add to my MEDBOX

Advocacy Guide: HIV/AIDS Prevention among injecting drug users

A. Ball; M. Beg; G. Weiler; et al. World Health Organization; UNAIDS; United Nations on Drugs and Crime (2004) C_WHO
 Add to my MEDBOX

Policy Guidelines for Collaborative TB and HIV Services for Injecting and Other Drug Users: An Integrated Approach

World Health Organization, UNAIDS, United Nations Office on Drugs and Crime (2008)
These policy guidelines provide a strategic approach and new recommendations for integrated TB and HIV services for patients suffering from substance-abuse addiction. The key recommendations fall under three main categories: joint planning, key interventions, and overcoming barriers.
 Download
  View PDF
 Add to my MEDBOX

Good governance for prison health in 21st century

World Health Organization (Europe); UNODC (United Nations Office on Drugs and Crime) (2013) C_WHO
A policy brief on the organization of prison health
 Download
  View PDF
 Add to my MEDBOX

Global update on HIV treatment 2013: Results, impact and opportunities

World Health Organization; UNICEF; UNAIDS (2013)
Chapter 1 provides new data on the latest developments in the global treatment effort, highlighting positive trends as well as aspects that require improvement. Chapter 2 summarizes the impact of the scale-up in reducing AIDS-related mortality and new HIV infections. Chapter 3 examines the sequence ... more
 Download
  View PDF
 Add to my MEDBOX

Patents and licences on antiretrovirals: A snapshot

UNITAID; WHO (2014)
The report provides a brief introduction to patents and licences and their effect on the market for antiretroviral (ARV) medicines. It gives an overview of the patent landscape with respect to a select number of ARV medicines in developing countries ... more
 External Link
 Add to my MEDBOX

2015 Pipeline Report HIV, Hepatitis C virus (HCV), and Tuberculosis (TB)

Polly Clayden, Simon Collins, Mike Frick, et al. A. Benzacar; HIV i-BASETREATMENT ACTION GROUP (2015)
Drugs, Diagnostics, Vaccines, Preventive Technologies, Research toward a cure, and immune-based and gene therapies in development
 External Link
 Add to my MEDBOX

Missed Opportunities for Early Access to Care of HIV-Infected Infants in Burkina Faso

Coulibaly M., N. Meda, C. Yonaba et al. PLOS ONE (2014) C2
The World Health Organization (WHO) has recommended a universal antiretroviral therapy (ART) for all HIVinfected children before the age of two since 2010, but this implies an early identification of these infants. We described the Prevention of Mot ... more
 Add to my MEDBOX

The Use of Co-Trimoxazole Prophylaxis for HIV-Related Infections among Adults, Adolsescents and Children

World Health Organization WHO (2014) C_WHO
Co-trimoxazole is a fixed-dose combination of two antimicrobial drugs (sulfamethoxazole and trimethoprim) that covers a variety of bacterial, fungal and protozoan infections. Co-trimoxazole preventive therapy is a feasible, well tolerated and inexpe ... more
 Download
  View PDF
 Add to my MEDBOX

Guide Material for Medical Store Management Training
recommended

Community Development Medicinal Unit (2012) C_WHO
Drugs and medical supplies are dispensed at the cutting edge level of the interface between the public health system and the people. Availability or lack of it brings either credit or discredit to the public health system. The primary reason for hol ... more
 Download
  View PDF
 Add to my MEDBOX

الأدوية الأساسية
recommended

Medécins sans Frontières (2022) C2
. MSF Essential Drugs Guidelines دليل عملي موجه للأطباء والصيادلة والممرضين والمساعدين الطبيين
 External Link
 Add to my MEDBOX

Guidelines - European AIDS Clinical Society (EACS)

European AIDS Clinical Society (EACS) European AIDS Clinical Society (EACS) (2020) C2
Version 10.1_5 October 2020 These Guidelines are available in different formats: As a paper booklet, a PDF, a mobile app, and now also as a website. The 2019 version of the Guidelines introduces a new drug-drug interaction panel and now consists of six main sections, including a general overview ... more
 Download
  View PDF
 Add to my MEDBOX

Policy Analysis and Advocacy Decision Model for HIV-Related Services

B. Pick; D. Wolfe; D. Burrows; F. Hariga; et al. USAID (From the American People); REPFAR; EURASIAN Harm Reduction Network; Health Policy Project (2012) C2
People Who Inject Drugs In addition, the following individuals of our external expert advisory committee made instrumental contributions to the initial design and content of the document: Billy Pick, USAID; Daniel Wolfe, Open Society Foundations; ... more
 Add to my MEDBOX

Information note on HIV and COVID-19

World Health Organization WHO (2020) C_WHO
People living with HIV depend on life-saving antiretroviral therapy (ART) and access to ART must be maintained during periods of travel restrictions and lockdowns resulting from the COVID-19 pandemic. The Information note on HIV and COVID-19 address ... more
 Download
  View PDF
 Add to my MEDBOX

HIV Pipeline 2018

i-base (2018) C2
htb supplement: 2018 Vol 19:(1) New drugs in development July 2018 www.i-Base.info
 Add to my MEDBOX

Malawi - HIV Country Profile 2024

World Health Organization WHO (2024) C_WHO
Demographic and socioeconomic data Progress towards HIV testing and treatment cascade targets by 2025 (2023) Health sector cascade (2023) Estimated number of people newly infected with HIV
 Download
  View PDF
 Add to my MEDBOX

Guidelines for the Clinical Management of HIV Infection in Myanmar, 5th ed.
recommended

The Republic of the Union of Myanmar, Ministry of Health, Department of Health, National AIDS Programme World Health Organization (WHO), Country Office for Myanmar (2017) C1
These guidelines aim to guide all health care providers in Myanmar, accommodating the situation of different settings in the context of progressive decentralization of HIV services. Notable changes from the previous edition include:
• diagnosis of HIV
• update on the initiation of ART
... more
 Add to my MEDBOX

Updated Recommendations Onservice Delivery For The Treatment And Care Of People Living With HIV. Summary Slides
recommended

World Health Organization WHO (2021) C_WHO
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antire ... more
 Download
  View PDF
 Add to my MEDBOX

Consolidated HIV guidelines for prevention, treatment, service delivery & monitoring
recommended

World Health Organization WHO (2021) CC
July 2021. This publication brings together important clinical and programmatic updates produced by WHO since 2016 and provides comprehensive, evidence-informed recommendations and good practice statements within a public health, rights-based and person-centred approach. These guidelines bring in ... more
 Download
  View PDF
 Add to my MEDBOX

Recomendaciones para el tratamiento antirretroviral de niños, niñas y adolescentes con infección por VIH-1

Ministerio de Salud Argentina (2022) C2
Resumen para Equipos de Salud Edición 2021-2022 Las presentes recomendaciones se encuentran dirigidas a los miembros del equipo de salud que asisten niñas, niños y adolescentes (NNyA) que viven con VIH. También se dirigen a los responsables jurisdiccionales que participan en el proceso de gesti ... more
 Download
  View PDF
 Add to my MEDBOX

Harmonized monitoring and evaluation indicators for procurement and supply management systems

WHO (2011) C_WHO
Early-warning indicators to prevent stock-outs and overstocking of antiretroviral, antituberculosis and antimalaria medicines.
 Download
  View PDF
 Add to my MEDBOX

Double Trouble: Injection Drug Use and Sexual Behaviour

Bhattacharya A, et al. India HIVAIDS Alliance; Hridaya Harm Reduction in India (2015) C1
Findings from a cross-sectional qualitative study of HIV vulnerabilities among People Who Inject Drugs and their sex partners in Bihar and Manipur, India. The study is one of the first qualitative comparative studies to seek an in-depth understandin ... more
 Download
  View PDF
 Add to my MEDBOX

The impact of drug policy on health and human rights in Eastern Europe

M. Hoekstra Eurasian Harm Reduction Network (2009) C2
10 years after the UN general assembly special session on drugs
 Download
  View PDF
 Add to my MEDBOX

NATIONAL GUIDELINES FOR COMPREHENSIVE CARE OF PEOPLE LIVING WITH HIV IN RWANDA

Ministry of Health, Rwanda (2011) C2
This guide presents new knowledge and guidelines on the provision of care to persons living with HIV/AIDS, in accordance with the last guidelines of the World Health Organization (WHO) published in 2006 and adapted to the Rwandan national context. It thus responds to the need by the Ministry of Heal ... more
 Add to my MEDBOX

Dolutegravir Resistance in Malawi’s National HIV Treatment Program

van Ossterhout, J. J.; Chipungu, C.; Nkhoma, L. et all. (2022) CC2
Dolutegravir HIV drug resistance (HIVDR) data from Africa remain sparse. We reviewed HIVDR results of Malawians on dolutegravir-based antiretroviral therapy (November 2020– September 2021). Of 6462 eligible clients, 33 samples were submitted to S ... more
 External Link
 Add to my MEDBOX

Implications of differentiated care for successful ART scale up in a concentrated HIV epidemic in Yangon, Myanmar

Mesic, Anita; Fontaine, Julie; Theingy Aye et al. (2017) CC
Journal of the International AIDS Society 2017, 20(Suppl 4):21644
National AIDS Programme in Myanmar has made significant progress in scaling up antiretroviral treatment (ART) services and recognizes the importance of differentiated care for pe ... more
 Download
  View PDF
 Add to my MEDBOX

The role of HIV viral suppression in improving individual health and reducing transmission

World Health Organisation (WHO) (2023) C_WHO
This policy brief describes key HIV viral load thresholds and the available viral load testing approaches for monitoring how well antiretroviral therapy is working for people living with HIV. It provides clarification for and elaborates upon the cur ... more
 Download
  View PDF
 Add to my MEDBOX

TB/HIV integration

AIDS and Rights Alliance for Southern Africa (2017) C2
TB heroes Hello, my name is Nurse X My job is to promote integrated HIV and TB prevention, care, treatment and support. This ensures that we, and my team of health care service providers treat everyone who is living with HIV and TB to have all the antire ... more
 Download
  View PDF
 Add to my MEDBOX

Reconsidering Primary Prevention of HIV: New Steps Forward in the Global Response

Ayala, George; Chang, Judy et al. Global Forum on MSM & HIV (2017) C1
The uneven distribution of HIV risks and burdens across populations is a well-substantiated fact, though seldom publicly acknowledged. Gay men and other men who have sex with men, people who inject drugs, sex workers, and transgender women are 24, ... more
 Download
  View PDF
 Add to my MEDBOX

Global AIDS Response Progress Report Myanmar

The Republic of the Union of Myanmar, Ministry of Health (2015) C1
Reporting period: January 2014 – December 2014
The human immunodeficiency virus (HIV) epidemic in Myanmar is concentrated among men who have sex with men (MSM), people who inject drugs (PWID) and female sex workers (FSW). HIV prevalence in th ... more
 Download
  View PDF
 Add to my MEDBOX

Characteristics and Treatment Outcomes of Retreatment Tuberculosis Patients in Benin

Serge Ade, Omer Adjibodé, Prudence Wachinou, Narcisse Toundoh, Bérénice Awanou, Gildas Agodokpessi, Dissou Affolabi, Gabriel Adè, Anthony D. Harries, Séverin Anagonou Hindawi (2016) C2
Patients with retreatment tuberculosis (TB) represent those who have been treated previously for onemonth ormorewith anti-TB drugs and who have been diagnosed once again with the disease.These patientsmainly include relapses, treatment after fai ... more
 Download
  View PDF
 Add to my MEDBOX

HIV and Infant Feeding in Emergencies: Operational Guidance

World Health Organization (WHO) (2018) C_WHO
The duration of breastfeeding and support from health services to improve feeding practices among mothers living with HIV
This operational guidance, developed by WHO, UNICEF and ENN, outlines the duration of breastfeeding and support from health services to improve infant feeding practices amon ... more
 Download
  View PDF
 Add to my MEDBOX

National Acceleration Plan For Paediatric HIV Services: Ghana 2016 - 2020

United Nations Children’s Fund (UNICEF) (2016) C1
In 2014, GHS/NACP, with support from UNICEF and other partners, conducted a situation analysis on paediatric HIV care and treatment in Ghana. The purpose of this analysis was to identify the gaps within the current delivery of paediatric HIV care and support system and develop a road map for effecti ... more
 External Link
 Add to my MEDBOX

Retention and mortality outcomes from a community-supported public–private HIV treatment programme in Myanmar

Mburu, Gitau; Aung Zayar Paing; Nwe Ni Myint et al. (2016) CC
Journal of the International AIDS Society 2016, 19:20926
There is a growing interest in the potential contribution the private sector can make towards increasing access to antiretroviral therapy (ART) in low‐ and middle‐income settings. Thi ... more
 Download
  View PDF
 Add to my MEDBOX

Vietnam: National Action Plan on Combating Drug Resistance in the period from 2013 - 2020

Ministry of Health Vietnam (2013) C2
In Vietnam, most of the examination and treatment facilities are facing with of spread of bacteria resistant to many antibiotics. The level and speed of drug resistance are increasing, at alarming level. The burden of drug resistance is increasing due to the increasing cost of treatment, prolonged t ... more
 Download
  View PDF
 Add to my MEDBOX

Management & Post-Exposure Prophylaxis of Potential HIV and Hepatitis B Exposure in Children, Adolescents & Adults Guidelines (South Africa)

Western Cape Government Health, South Africa (2019) C1
1PEP GUIDELINES | 2019 EDITION. The prevalence of both HIV and Hepatitis B is high in South Africa therefore there is a significant risk of acquiring these infections following exposure to infected material. Studies suggest that post- exposure prophylaxis (PEP) with highly active ... more
 Download
  View PDF
 Add to my MEDBOX

The impact of transition from Global Fund support to govermental funding on the sustainability of Harm Reduction programs

G. Shaw Eurasian Harm Reduction Network; ICASO (2016) C2
A case study from Albania June 2016 EHRN is grateful to all who contributed to this document, especially (in alphabetical order): Alena Alba, Program Officer, Eastern Europe and Central Asia Team, Asia, Europe, Latin America and the Caribbean Department, The Global Fund to Fight AIDS, Tuberc ... more
 Add to my MEDBOX

Guidelines for Implementing Collaborative TB and HIV Programme Activities

Stop TB Partnership. Working Group on TBHIV. Scientific Panel WHO (2003) C_WHO
The main aim of these guidelines is to enable the central units of national TB and HIV/AIDS programmes to support districts to plan, coordinate and implement collaborative TB/HIV activities. These guidelines reinforce current medical understanding, that highly active ... more
 Add to my MEDBOX

National HIV/AIDS Programs - A Handbook on Supply Chain Management for HIV/AIDS Medical Commodities

Sangeeta Raja and Nadeem Mohammad ACTafrica, HNP (2005) C1
The handbook on supply chain management for HIV/AIDS commodities was written to assist program managers to plan and implement day–to-day management of all drugs and medical supplies for an HIV/AIDS program. Many of the suggest ... more
 External Link
 Add to my MEDBOX

Alternative Thematic Report on implementation of the Convention on Elimination of all Forms of discrimination against Women on the issues related to women living with HIV from the affected groups

Republic of Tajikistan; Tajikistan Network of Women living with HIV (Public Organization) (2019) C2
Alternative Thematic Report on implementation of the Convention on Elimination of all Forms of discrimination against Women on the issues related to women living with HIV from the affected groups (women – former prisoners, women using injected drugs ... more
 Download
  View PDF
 Add to my MEDBOX

Integration of HIV testing and linkage in family planning and contraception services: implementation brief

World Health Organisation (WHO) (2021) C_WHO
This implementation brief addresses integration of HIV testing services into family planning (FP) services. It is intended as a practical resource for national health programmes seeking to introduce or scale up HIV testing and linkage to HIV prevention, sexually transmitted infection, and ... more
 Download
  View PDF
 Add to my MEDBOX

UNAIDS data-2021

UNAIDS (2021) C_CDC
Global and Regional Data 1 December 2021; The 90–90–90 targets were missed, but not by much. At the end of 2020, 84% of people living with HIV knew their HIV status, 87% of people living with HIV who knew their HIV status were accessing antiretroviral ... more
 Download
  View PDF
 Add to my MEDBOX

Health should not be a privilege for the rich—the right to health belongs to everyone

UNAIDS (2020) CC
UNAIDS is calling on governments to ensure that the right to health is realized by all by prioritizing public investments in health. At least half of the world’s population cannot access essential health services. Every two minutes a woman dies while giving birth. Among the people being left behin ... more
 Add to my MEDBOX

Worldwide rates of diagnosis and effective treatment for cystic fibrosis

Guo, J.; Garratt, A.; Hill, A. Journal of Cystic Fibrosis (2022) CC
Time has seen management for Cystic Fibrosis (CF) advance drastically, most recently in the development of the disease-modifying triple combination therapy ivacaftor/tezacaftor/elexacaftor. There is currently limited evidence regarding both the global epidemiology of CF and access to this transforma ... more
 Add to my MEDBOX

Management of MDR-TB: A field guide

Partners in Health, World Health Organization (2009) C_WHO
Multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) increasingly occur in resource-constrained settings. In the context of a national response to MDR- and XDR-TB, health workers in TB clinics (in district hospitals and some accredited health centres) wil ... more
 Download
  View PDF
 Add to my MEDBOX

We are also dying of AIDS

Human Rights Watch (2014) C1
Barriers to HIV Services and Treatment for Persons with Disabilities in Zambia The 80-page report documents the obstacles faced by people with disabilities in both the community and healthcare settings. These include pervasive stigma and discrimination, lack of access to inclusive HIV prevention ed ... more
 Download
  View PDF
 Add to my MEDBOX

The National Tuberculosis Health Sector Strategic Plan 2015-2020
recommended

Bonsu FA, Hanson-Nortey NN, Afutu FK et al. Ghana, Ministry of Health (2014) C1
The mandate of the National Tuberculosis Control Programme is to provide leadership and stewardship to accelerate intense and coordinated efforts to reduce the adult TB burden of 290 per 100,000 population recently established in the 2013 National TB Prevalence Survey. Other key challenges are low T ... more
 Download
  View PDF
 Add to my MEDBOX

WHO consolidated guidelines on drug-resistant tuberculosis treatment
recommended

World Health Organization WHO; Stop TB (2019) C_WHO
The present Consolidated guidelines include a comprehensive set of WHO recommendations for the treatment and care of DR-TB, derived from these WHO guidelines documents. The consolidated guidelines include policy recommendations on treatment regimens for isoniazid-resistant TB (Hr-TB) and MDR/RR-TB, ... more
 Add to my MEDBOX

Antibiotic use and resistance in South Africa

Dr T Apalata, Dr C Bamford, Mr D Benjamin et al. South African Medical Journey SAMJ (2011) C2
Antimicrobial resistance (AMR) is an important public health concern shared by developed and developing countries. In developing countries the burden of infectious diseases is greater and exacerbated by limited access to, and availability and affordability of, antimicrobials required to treat infect ... more
 Add to my MEDBOX

National Strategy for Containment of Antimicrobial Resistance in Turkmenistan

MINSITRY OF HEALTH AND MEDICAL INDUSTRY OF TURKMENISTAN (2018) C_WHO
Spread of resistance to antimicrobial agents (AMR) does not know national borders and has reached dimensions, which require immediate actions at the national, regional and global levels. Antibiotic resistance is a natural biological response to improper use of antimicrobial agents (AMA); increasing ... more